v3.25.2
Financial instruments (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Financial instruments fair value gains          
Net (losses)/gains on equity investments measured at fair value through other comprehensive income $ (67) $ 54 $ (125) $ 89  
Non-cash and other movements     304 (550)  
Net cash inflow from operating activities     7,099 5,571  
Reconciliation of changes in contingent liabilities in business combination          
Contingent liabilities recognised in business combination at beginning of period     1,751 2,137  
Additions       198  
Settlements     (629) (474)  
Revaluations     (30) 251  
Discount unwind     32 57  
Contingent liabilities recognised in business combination at end of period 1,124 $ 2,169 1,124 2,169  
Diabetes alliance          
Reconciliation of changes in contingent liabilities in business combination          
Contingent liabilities recognised in business combination at beginning of period     1,309    
Settlements     (518)    
Revaluations     (30)    
Discount unwind     21    
Contingent liabilities recognised in business combination at end of period 782   782    
Increase/decrease in contingent consideration balance with change in current estimates 78   $ 78    
Percentage of reasonably possible increase or decrease in sales estimates     10.00%    
Other          
Reconciliation of changes in contingent liabilities in business combination          
Contingent liabilities recognised in business combination at beginning of period     $ 442    
Settlements     (111)    
Discount unwind     11    
Contingent liabilities recognised in business combination at end of period 342   342    
Interest-Bearing Loans and Borrowings | Not measured at fair value in statement of financial position but for which fair value is disclosed          
Financial instruments fair value gains          
Carrying value, financial liabilities 32,839   32,839    
Financial liabilities, at fair value 32,203   32,203    
Financial assets at amortised cost          
Financial instruments fair value gains          
Cash collateral pledged to counterparties 32   32    
Other Investments | Financial assets measured at fair value          
Financial instruments fair value gains          
Financial assets 1,880   1,880    
Money market funds | Financial assets measured at fair value          
Financial instruments fair value gains          
Financial assets 5,597   5,597    
Derivatives | Financial assets measured at fair value          
Financial instruments fair value gains          
Financial assets 504   504    
Level 3          
Financial instruments fair value gains          
Net (losses)/gains on equity investments measured at fair value through other comprehensive income     (35) $ 1  
Level 3 | Equity investments          
Financial instruments fair value gains          
Financial assets 523   523   $ 353
Level 3 | Equity investments | Financial assets measured at fair value          
Financial instruments fair value gains          
Financial assets $ 523   $ 523